Sho Ishikawa

1.6k total citations
67 papers, 1.3k citations indexed

About

Sho Ishikawa is a scholar working on Ophthalmology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sho Ishikawa has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 13 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sho Ishikawa's work include T-cell and B-cell Immunology (8 papers), Glaucoma and retinal disorders (7 papers) and Immune Cell Function and Interaction (7 papers). Sho Ishikawa is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Glaucoma and retinal disorders (7 papers) and Immune Cell Function and Interaction (7 papers). Sho Ishikawa collaborates with scholars based in Japan, United States and Singapore. Sho Ishikawa's co-authors include Kouji Matsushima, Azusa Kondoh, Masahiro Terada, Hiroyuki Yoneyama, Masaru Takeuchi, Naoko Kato, Satoshi Ueha, Yi Zhang, Kenjiro Matsuno and Masahiro Kitabatake and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

Sho Ishikawa

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sho Ishikawa Japan 17 571 275 169 167 158 67 1.3k
Christopher T. Turner Australia 20 200 0.4× 54 0.2× 94 0.6× 56 0.3× 487 3.1× 46 1.2k
Evelyne Colomb France 16 187 0.3× 104 0.4× 62 0.4× 62 0.4× 214 1.4× 26 752
Hongyan Zhou China 22 491 0.9× 1.2k 4.2× 115 0.7× 15 0.1× 439 2.8× 74 1.9k
O Förster Austria 15 415 0.7× 47 0.2× 181 1.1× 34 0.2× 344 2.2× 56 841
Harris E. McFerrin United States 14 95 0.2× 62 0.2× 39 0.2× 130 0.8× 216 1.4× 22 708
Jing-Feng Huang United States 17 923 1.6× 111 0.4× 156 0.9× 10 0.1× 555 3.5× 25 1.9k
Keith W. Wegmann United States 17 669 1.2× 19 0.1× 84 0.5× 28 0.2× 191 1.2× 29 1.2k
Guannan Su China 19 263 0.5× 652 2.4× 62 0.4× 9 0.1× 674 4.3× 104 1.8k
Theodore W. Sery United States 16 180 0.3× 552 2.0× 133 0.8× 14 0.1× 534 3.4× 39 1.4k
Fabian Käsermann Switzerland 18 504 0.9× 10 0.0× 395 2.3× 94 0.6× 345 2.2× 38 1.2k

Countries citing papers authored by Sho Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Sho Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Ishikawa more than expected).

Fields of papers citing papers by Sho Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Ishikawa. The network helps show where Sho Ishikawa may publish in the future.

Co-authorship network of co-authors of Sho Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Ishikawa. A scholar is included among the top collaborators of Sho Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Ishikawa. Sho Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ishikawa, Sho, et al.. (2024). A lacrimal drainage pathway disease-associated keratopathy (LDAK) case with non-infectious endophthalmitis. American Journal of Ophthalmology Case Reports. 36. 102212–102212.
3.
Ishikawa, Sho, et al.. (2023). Effect of a single warm compress prior to ophthalmic surgery on ocular surface and intraoperative visibility: a randomised controlled study. BMJ Open Ophthalmology. 8(1). e001307–e001307. 1 indexed citations
4.
Ishikawa, Sho, et al.. (2023). Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution. Journal of Clinical Medicine. 12(13). 4495–4495. 6 indexed citations
5.
Ishikawa, Sho, et al.. (2023). Modified Basket Suture for a Floppy or Irregular Iris in Endothelial Keratoplasty. Cornea. 42(11). 1465–1468.
6.
Shoji, T., Yuji Yoshikawa, Hirokazu Ishii, et al.. (2020). Comparison of central visual sensitivity between monocular and binocular testing in advanced glaucoma patients using imo perimetry. British Journal of Ophthalmology. 104(11). bjophthalmol–2019. 11 indexed citations
7.
Yoshikawa, Yuji, Sho Ishikawa, Masayuki Shibuya, et al.. (2019). Electroretinograms recorded with skin electrodes in silicone oil-filled eyes. PLoS ONE. 14(5). e0216823–e0216823. 7 indexed citations
8.
Ishikawa, Sho, et al.. (2019). A case with acquired lacrimal fistula due to Sjögren's syndrome. American Journal of Ophthalmology Case Reports. 15. 100526–100526. 2 indexed citations
9.
Shoji, T., Naoko Kato, Sho Ishikawa, et al.. (2019). Association between axial length and in vivo human crystalline lens biometry during accommodation: a swept-source optical coherence tomography study. Japanese Journal of Ophthalmology. 64(1). 93–101. 19 indexed citations
10.
Inoue, Akira, Tsunekazu Mizushima, Xin Wu, et al.. (2018). A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS -Mutant Colon Cancer Cells. Molecular Cancer Therapeutics. 17(5). 977–987. 30 indexed citations
11.
Ishikawa, Sho, Naoko Kato, & Masaru Takeuchi. (2018). Quantitative evaluation of corneal epithelial edema after cataract surgery using corneal densitometry: a prospective study. BMC Ophthalmology. 18(1). 334–334. 27 indexed citations
12.
Ishikawa, Sho, Naoko Kato, & Masaru Takeuchi. (2016). The Efficacy of Strip Meniscometry and DEQS for Dry Eye Screening during Medical Health checkups. Investigative Ophthalmology & Visual Science. 57(12). 2852–2852. 2 indexed citations
13.
Takayama, Kei, et al.. (2015). Evaluation of Microincision Vitrectomy Surgery Using Wide-Viewing System for Complications With Ocular Sarcoidosis. Medicine. 94(7). e559–e559. 10 indexed citations
14.
Shibata, Masaki, et al.. (2014). Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. British Journal of Ophthalmology. 98(7). 932–936. 37 indexed citations
15.
Nakano, Akiko, Hiroyuki Yoneyama, Satoshi Ueha, et al.. (2007). Intravenous administration of MIP-1α with intra-tumor injection of P. acnes shows potent anti-tumor effect. International Immunopharmacology. 7(6). 845–857. 7 indexed citations
16.
Ito, Toshihiro, Sho Ishikawa, Taku Sato, et al.. (2004). Defective B1 Cell Homing to the Peritoneal Cavity and Preferential Recruitment of B1 Cells in the Target Organs in a Murine Model for Systemic Lupus Erythematosus. The Journal of Immunology. 172(6). 3628–3634. 59 indexed citations
17.
Yurino, Hideaki, Sho Ishikawa, Taku Sato, et al.. (2004). Endocrine Disruptors (Environmental Estrogens) Enhance Autoantibody Production by B1 Cells. Toxicological Sciences. 81(1). 139–147. 87 indexed citations
18.
Ishikawa, Sho, et al.. (2000). [An autopsy case of primary cerebellar-pontine angle epidermoid carcinoma].. PubMed. 40(3). 243–8. 7 indexed citations
19.
Ishikawa, Sho, T Atsumi, N Shimizu, Saburo Omata, & T. Miyatake. (1978). [A case of hypokalemic myopathy in patient with primary aldosteronism and complicated with thyroid cancer (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(8). 455–61. 1 indexed citations
20.
Naito, Satoshi & Sho Ishikawa. (1971). [Convergent strabismus and the miotics. 3. Accommodative esotropia and the bifocals].. PubMed. 75. 794–801. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher T. Turner Breakdown of academic impact, for papers by Evelyne Colomb Breakdown of academic impact, for papers by Hongyan Zhou Breakdown of academic impact, for papers by O Förster Breakdown of academic impact, for papers by Harris E. McFerrin Breakdown of academic impact, for papers by Jing-Feng Huang Breakdown of academic impact, for papers by Keith W. Wegmann Breakdown of academic impact, for papers by Guannan Su Breakdown of academic impact, for papers by Theodore W. Sery Breakdown of academic impact, for papers by Fabian Käsermann
Rankless by CCL
2026